Successful treatment of “accelerated” chronic lymphocytic leukemia with single agent ibrutinib: A report of two cases.

Successful treatment of “accelerated” chronic lymphocytic leukemia with single agent ibrutinib: A report of two cases.

“Accelerated” chronic lymphocytic leukemia/small lymphocytic lymphoma (A-CLL) is a rare histological variant of CLL/SLL, which tends to exhibit an aggressive clinical behavior compared to CLL. Due to the rarity of A-CLL (<1% of all cases), the optimal management remains ill-defined. We report two...

Full description

Bibliographic Details
Main Authors: John Xie, Albert Jang, Andrew Vegel, Yasmin Hajja, Yara Mouawad, Ali Baghian, Bachir Berbari, Janet L. Schmid, Francisco Socola, Hana Safah, Nakhle S. Saba
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Leukemia Research Reports
Subjects:
CLL
SLL
Ibrutinib
Accelerated
Online Access:http://www.sciencedirect.com/science/article/pii/S2213048921000145

Internet

http://www.sciencedirect.com/science/article/pii/S2213048921000145

Similar Items